Explained: How coronavirus has disrupted access to Parkinson's medication
September 24, 2020 5:30 pm
The responses indicated that 88.9 per cent of those in low-income countries considered access to Parkinson’s disease medication to have been affected by Covid-19, compared with 22.8 per cent of those in high income countries.
.png)
No hay comentarios:
Publicar un comentario